glycolipid synthesis inhibitors (Genzyme/University of Michigan)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameglycolipid synthesis inhibitors (Genzyme/University of Michigan)
Drug Alias Nameglucosylceramide synthase inhibitors (Genzyme/University of Michigan)EDO-P4
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCeramide glucosyltransferase inhibitors
TargetsCeramide glucosyltransferase
Therapy Area/IndicationsLysosomal Storage DiseasesGaucher DiseaseFabry Disease +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Michigan
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenzyme GeneralUniversity Of Michigan
Active IndicationsN/A
Inactive IndicationsLysosomal Storage DiseasesGaucher DiseaseFabry Disease +[5] 

Other Information

ATC CodeN/A
Related LinksN/A